NEWS PROVIDED BY Codman Neuro | 10 Apr, 2017, 07:00 ET IRVINE, Calif., April 10, 2017 /PRNewswire/ — Codman Neuro today announced the acquisition of Neuravi Limited, a privately held Irish company dedicated to advancing neurovascular therapies and improving clinical outcomes for acute ischemic stroke patients. This acquisition, and the recent […]
Tag: Neurovascular
Metactive Medical Announces Issuance of Patents on Blockstent and Ballstent Embolization Devices
OLATHE, Kan.–(BUSINESS WIRE)–Metactive Medical Inc. (Metactive), an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, today announced the issuance of US Patents 9,572,697 and 9,572,698 covering its Ballstent Microcatheter™ for embolization of cerebral aneurysms, and its Blockstent Microcatheter™ for embolization of peripheral […]
Stryker Announces an Early Stop to Enrollment in the DAWN™ Trial Due to the High Probability of Trial Success
KALAMAZOO, MICHIGAN (PRWEB) MARCH 08, 2017 Stryker announced an early end to patient enrollment in the DAWN Trial, a clinical study designed to compare mechanical thrombectomy with the Trevo® Retriever plus medical therapy against medical therapy alone when initiated within six to 24 hours after time last known well. The […]



